Disease/Infection News

RSS

Bio-Rad receives MicroVal validation for EZ-Check™ Listeria testing kits

Bio-Rad Laboratories, Inc., a leader in life science research and clinical diagnostics products, today announced that MicroVal, the international certification organization for the validation and approval of alternative methods for the microbiological analysis of food and beverages, has approved EZ-Check Listeria spp. and EZ-Check Listeria monocytogenes Kits for the detection of Listeria spp. and Listeria monocytogenes in food products and environmental samples.

From Bio-Rad Laboratories 5 Jun 2026

Flu drugs may reduce cognitive decline in people with HIV

A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection, reports a new study led by Northwestern University that began with blood samples from people with HIV and extended into preclinical drug trials.

5 Jun 2026

Home sewage overflows expose residents to dangerous drug-resistant bacteria

A new study shows that sewage overflows in homes can expose people to bacteria that can make them sick, including antibiotic-resistant and multidrug resistant bacteria which can make infections difficult to treat.

5 Jun 2026

UK manufacturer supplying Ebola response warns infection-control readiness cannot wait for crisis

As health agencies respond to the current Ebola outbreak in Central Africa, a UK manufacturer supplying water purification products for direct distribution in affected communities is warning that infection-control readiness must be planned long before an emergency takes hold.

5 Jun 2026

Untargeted metabolomics approach identifies potential biomarkers for latent tuberculosis diagnosis

Announcing a new article publication in BIO Integration. Latent tuberculosis infection (LTBI) is difficult to diagnose due to the lack of a definitive gold standard.

5 Jun 2026

Randox Health launches 'RanChip Insights 360'

Randox Health today announces the launch of RanChip Insight 360, an advanced health intelligence programme designed to transform how individuals understand, monitor, and manage their long-term wellbeing.

From Randox Laboratories Ltd. 5 Jun 2026

Scientists discover new intracellular immune defense against infections

When we think of the immune system, most people imagine white blood cells putting up a fight against invading germs within our bloodstream.

4 Jun 2026

EU-funded project launches digital campaign to explain climate-driven food safety threats

To mark World Food Safety Day on 7 June, the EU-funded HOLiFOOD project is launching a digital campaign with six European influencers to help consumers better understand how climate change may affect food safety, and how science can support earlier detection and prevention of emerging risks.

4 Jun 2026

Rice-fish coculturing may reduce schistosomiasis and poverty

The chronic disease schistosomiasis wreaks havoc on more than 220 million people around the world, with the vast majority of cases being in sub-Saharan Africa.

4 Jun 2026

Universal Sarbeco coronavirus vaccine proves safe in first human trial

The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side-effects.

4 Jun 2026

What older adults eat may shape dementia risk

Higher ultraprocessed food intake was associated with increased risks of dementia, cognitive impairment with no dementia, and the combined outcome among older US adults in the Health and Retirement Study. Minimally processed food intake showed the opposite pattern, although the observational findings require cautious interpretation because diet was self-reported and cognitive outcomes were not clinically diagnosed.

4 Jun 2026

Real-world study exposes suboptimal adherence to treat-to-target rheumatic strategies

EULAR - The European Alliance of Associations for Rheumatology - acknowledges the role of diverse real-world data to complement knowledge from randomized controlled trials.

4 Jun 2026

New data confirms dengue vaccine safety for older and chronic-risk travelers

Data from 1,028 people vaccinated with TAK-003 in Catalonia suggests that the dengue vaccine has a good tolerability profile in routine clinical practice among travelers from regions where dengue is not endemic.

4 Jun 2026

New index identifies HIV prevention gaps across the Southern United States

The University of Mississippi-led study, published in Frontiers in Public Health, offers health care and government leaders a new tool for targeting HIV-related support where the need is highest.

3 Jun 2026

New manufacturing platform produces targeted mixtures of beneficial gut bacteria

Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted mixtures of beneficial gut bacteria, an approach that could help expand access to microbiome-based therapies for patients with recurrent Clostridioides difficile (C. difficile) infection.

3 Jun 2026

Modified injectable vaccine shows promise for complete polio eradication

In the United States, children routinely receive an injectable form of the polio vaccine. This vaccine is very effective at preventing illness, but it doesn't block transmission of the polio virus as well as the oral polio vaccine does.

3 Jun 2026

New predictive model helps track dangerous animal viruses

A new predictive model developed at Washington State University could help scientists more efficiently identify the reservoirs of emerging zoonotic viruses and dangerous pathogens like Ebola that can spill over from animals into humans.

3 Jun 2026

Giving antibiotics for throat infections overrates their power against sepsis

Antibiotics for sore throats have hardly any preventive effect against serious streptococcal infections in the population, according to a study from the University of Gothenburg.

3 Jun 2026

Three-drug strategy forces pancreatic tumors into lasting regression

A triple-targeted preclinical therapy combining daraxonrasib, afatinib, and SD36 drove durable pancreatic cancer regression by blocking KRAS/RAS, EGFR/HER2, and STAT3 signaling. The approach prevented treatment resistance across mouse and human tumor-derived models, but remains preclinical and requires more clinically suitable drug combinations before human testing.

2 Jun 2026

Is any level of alcohol safe? Major review reveals where drinking risks rise

This Burden of Proof review found that alcohol consumption is associated with higher risks for several cancers, liver disease, pancreatitis, lower respiratory infections, tuberculosis, and atrial fibrillation. Although low-to-moderate drinking showed modest observational links with lower risks of type 2 diabetes, dementia, and some cardiovascular outcomes, the evidence was weaker and potentially biased.

2 Jun 2026